QUESTRAN

Product NDC: 49884-936
Requested package NDC: 49884-936-65
11-digit product format: 498840936
Labeler code: 49884
Product ID: 49884-936_ad7006dd-1ffb-4d96-878c-c502d37f7f8c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cholestyramine
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Endo USA, Inc.
Application: ANDA077204
Marketing category: ANDA
Marketing start: 2005-09-15
Substance: CHOLESTYRAMINE
Active strength: 4 g/9g
Pharmacologic classes: Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	49884-936	49884-936-65	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077204-001	CHOLESTYRAMINE	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB		2005-08-26
A077204-002	CHOLESTYRAMINE	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB		2005-08-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077204-001	AB
A077204-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077204-001	CHOLESTYRAMINE	EQ 4GM RESIN/PACKET	POWDER / ORAL	AB	2005-08-26	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077204-002	CHOLESTYRAMINE	EQ 4GM RESIN/SCOOPFUL	POWDER / ORAL	AB	2005-08-26	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A077204-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077204-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077204-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077204-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077204-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077204-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077204-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077204-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077204-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077204-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077204-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077204-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077204-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077204-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077204-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077204-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077204-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077204-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077204-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077204-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077204-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077204-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077204-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077204-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077204-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077204-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077204-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077204-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077204-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077204-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077204-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077204-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077204-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077204-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077204-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077204-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077204-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077204-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077204-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077204-002	AB	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: QUESTRAN
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CHOLESTYRAMINE	4 g/9g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4B33BGI082	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
848943	Internal RxNorm lookup
848949	Internal RxNorm lookup
1801279	Internal RxNorm lookup
1801280	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
362ddd91-a63f-4ec6-841a-75785dd208c8	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bafdcfac-da3a-43c4-81f4-296b60084636	Product name	6	20250623
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
49884-936-64	QUESTRAN	9 g in 1 PACKET	POWDER, FOR SUSPENSION	9	12
49884-936-65	QUESTRAN	60 in 1 CARTON	POWDER, FOR SUSPENSION	60	12
49884-936-66	QUESTRAN	378 g in 1 CAN	POWDER, FOR SUSPENSION	378	12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
49884-936-64	EA - Each	49884-936	f04e0703-846f-4dc7-bb2f-03532d99a4af	1	2013-02-13
49884-936-65	EA - Each	49884-936	8f59efdf-4316-4d96-9b7d-6dd39655d2be	1	2012-07-24
49884-936-66	GM - Gram	49884-936	15c02deb-95fe-4c6f-b4b3-1d489f61ad15	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CHOLESTYRAMINE	ACTIVE INGREDIENT	4B33BGI082	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
CHOLESTYRAMINE	ACTIVE MOIETY	4B33BGI082	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
ACACIA	INACTIVE INGREDIENT	5C5403N26O	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
PROPYLENE GLYCOL ALGINATE	INACTIVE INGREDIENT	26CD3J2R0C	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5
SUCROSE	INACTIVE INGREDIENT	C151H8M554	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49884-936	QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [ENDO USA, INC.]	12	Current NDC, Legacy NDC, 3 package rows	20250112_362ddd91-a63f-4ec6-841a-75785dd208c8.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cholestyramine	CHOLESTYRAMINE	Bryant Ranch Prepack	cc447b99-e654-42dd-8cf1-f9e7952a25cd	2026-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077204 application number: ANDA077204
Cholestyramine	CHOLESTYRAMINE	Bryant Ranch Prepack	2998a314-deb2-4a02-afab-7e8c868888e2	2026-07-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077204 application number: ANDA077204
Cholestyramine	CHOLESTYRAMINE	Par Health USA, LLC	b0c65058-22c3-4f57-9b61-9bc6fcd6e240	2026-06-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077204 application number: ANDA077204
QUESTRAN	CHOLESTYRAMINE	Endo USA, Inc.	362ddd91-a63f-4ec6-841a-75785dd208c8	2024-11-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077204 application number: ANDA077204 ndc (package): 49884-936-65 ndc (product): 49884-936 ndc11 (package): 49884093665

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4B33BGI082	CHOLESTYRAMINE	11041-12-6	CHOLESTYRAMINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
848943	cholestyramine resin 4 GM Powder for Oral Suspension	PSN	362ddd91-a63f-4ec6-841a-75785dd208c8	12
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	PSN	362ddd91-a63f-4ec6-841a-75785dd208c8	12
848949	Questran 4 GM Powder for Oral Suspension	PSN	362ddd91-a63f-4ec6-841a-75785dd208c8	12
1801280	Questran Light 4 GM Powder for Oral Suspension	PSN	362ddd91-a63f-4ec6-841a-75785dd208c8	12
848949	cholestyramine resin 4000 MG Powder for Oral Suspension [Questran]	SBD	362ddd91-a63f-4ec6-841a-75785dd208c8	12
1801280	Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension [Questran]	SBD	362ddd91-a63f-4ec6-841a-75785dd208c8	12
848943	cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	362ddd91-a63f-4ec6-841a-75785dd208c8	12
1801279	Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension	SCD	362ddd91-a63f-4ec6-841a-75785dd208c8	12
848943	cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension	SY	362ddd91-a63f-4ec6-841a-75785dd208c8	12
848943	cholestyramine resin 4 GM Powder for Oral Suspension	SY	362ddd91-a63f-4ec6-841a-75785dd208c8	12
1801279	cholestyramine Sugar-Free 4 GM Powder for Oral Suspension	SY	362ddd91-a63f-4ec6-841a-75785dd208c8	12
848949	Questran 4 GM Powder for Oral Suspension	SY	362ddd91-a63f-4ec6-841a-75785dd208c8	12
1801280	Questran Light 4 GM Powder for Oral Suspension	SY	362ddd91-a63f-4ec6-841a-75785dd208c8	12
1801280	Questran Sugar-Free 4000 MG Powder for Oral Suspension	SY	362ddd91-a63f-4ec6-841a-75785dd208c8	12

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
49884-936-65	49884093665	60 PACKET in 1 CARTON (49884-936-65) / 9 g in 1 PACKET (49884-936-64)	60 packet	2005-09-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Questran Powder for Oral Suspension	Par Health USA, LLC	2026-04-17	HUMAN PRESCRIPTION DRUG LABEL	13